eCTD 4.0 isn’t coming. It’s already here and most pharma teams aren’t ready.
New validation rules are catching organisations off guard. AI tools are reshaping how dossiers are built. And CMC, PV, and clinical teams can no longer leave electronic submission compliance to regulatory operations alone.
Our latest blog covers what actually matters in 2026 no jargon, no 40-point checklists:
What’s changed in eCTD specs and where submissions are failing
How AI document management works in practice and its limits
How CMC, PV, and clinical must coordinate for submission success
Practical steps to streamline your electronic submissions now
Read the full blog: https://www.vigilarebp.com/blogs/ectd-trends-in-2026-essential-updates-for-cmc-pv-clinical-teams/
